Prosecution Insights
Last updated: July 17, 2026
Application No. 19/012,393

OSTEOTOMY SYSTEMS, DEVICES AND METHODS

Non-Final OA §102§112§DP
Filed
Jan 07, 2025
Priority
Oct 24, 2016 — provisional 62/411,768 +4 more
Examiner
SEVILLA, CHRISTIAN ANTHONY
Art Unit
3775
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Paragon 28 Inc.
OA Round
1 (Non-Final)
76%
Grant Probability
Favorable
1-2
OA Rounds
2y 0m
Est. Remaining
95%
With Interview

Examiner Intelligence

Grants 76% — above average
76%
Career Allowance Rate
540 granted / 712 resolved
+5.8% vs TC avg
Strong +19% interview lift
Without
With
+19.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
17 currently pending
Career history
716
Total Applications
across all art units

Statute-Specific Performance

§101
1.8%
-38.2% vs TC avg
§103
68.0%
+28.0% vs TC avg
§102
18.9%
-21.1% vs TC avg
§112
7.5%
-32.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 712 resolved cases

Office Action

§102 §112 §DP
I. If desired, a PTO/SB/439 may optionally be filed to facilitate email correspondence. II. Upon further consideration, the restriction requirement is withdrawn. No claims are withdrawn. III. The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 5 and 7 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor, or for pre-AIA the applicant regards as the invention. The “zero degree angle” of claim 5 is unclear; for example, what is the angle relative to such that the angle is zero? It is unclear whether the “cutting slot” of claim 7 can be the slot of claim 1, or if the cutting slot was intended to be separate from the slot of claim 1 – the former interpretation will be considered to be within the BRI, i.e. broadest reasonable interpretation. IV. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention. Claims 1 and 2 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Stemniski et al. (US 2012/0271314). Regarding claim 1, Stemniski discloses an osteotomy system, comprising: an alignment device (e.g. 200); at least one first k-wire for insertion into the alignment device (e.g. [0117]); and a cut guide (e.g. 102) with at least one hole (e.g. 148) capable of receiving at least one second k-wire and a slot (e.g. 162) for receiving a saw blade. Regarding claim 2, Stemniski discloses a position rotation device (e.g. 132) with a plurality of openings capable of receiving a k-wire (e.g. Fig. 4). Claim 11 is rejected under 35 U.S.C. 102(a)(1) as being anticipated by Kolb (US 2006/0122607). Kolb discloses a bone plate (e.g. Fig. 4), comprising: a first portion (e.g. left interior portion) extending from a first end (e.g. top end) of the bone plate towards a second end (e.g. bottom end); a second portion (e.g. right interior portion) extending from the second end of the bone plate towards the first end; at least one opening (e.g. 14a) extending through the bone plate from a top surface to a bone contacting surface; a first lobe (e.g. one of three bulges on left per Fig. 4) extending away from a first side of the bone plate; and a second lobe (e.g. one of three bulges on right per Fig. 4) extending away from a second side of the bone plate. V. The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1-10 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-9 of U.S. Patent No. 10610241. Claims 12-20 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 11-19 of U.S. Patent No. 10610241. VI. Any inquiry concerning this communication or earlier communications from the examiner should be directed to CHRISTIAN A. SEVILLA whose telephone number is (571)270-56215621. The examiner can normally be reached on Monday through Thursday, 8:00 am to 5:00 pm. If attempts to reach the examiner by telephone are unsuccessful, please contact the examiner’s supervisor, KEVIN T. TRUONG, at 571-272-4705. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /CHRISTIAN A SEVILLA/ Primary Examiner, Art Unit 3775
Read full office action

Prosecution Timeline

Jan 07, 2025
Application Filed
Jun 23, 2026
Non-Final Rejection mailed — §102, §112, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12678175
Surgical Instrument System And Irrigation Sleeve
1y 10m to grant Granted Jul 14, 2026
Patent 12678176
GUIDANCE SYSTEM FOR HALLUX VALGUS CORRECTION
1y 8m to grant Granted Jul 14, 2026
Patent 12678297
BONE GRAFT DELIVERY DEVICES, SYSTEMS AND KITS
1y 8m to grant Granted Jul 14, 2026
Patent 12661238
BONY FUSION IMPLANT, INSERTION INSTRUMENT, AND METHODS
2y 0m to grant Granted Jun 23, 2026
Patent 12661240
SACROILIAC JOINT FUSION IMPLANTS, INSERTION INSTRUMENTS, AND METHODS
1y 9m to grant Granted Jun 23, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
76%
Grant Probability
95%
With Interview (+19.3%)
3y 7m (~2y 0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 712 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month